Clinical Trials Unit
Investigator-initiated multicenter trials, led end to end.
What we offer
- Trial design and protocol development
- FDA regulatory strategy, including IDE and IND submissions
- Coordinating-center leadership and project management
- Site activation, monitoring and safety oversight
- Data management and randomization systems
- Analysis, reporting and publication
Flagship
DUSK, a phase III trial of thrombectomy for distal medium vessel occlusion stroke (about DUSK). More trials are planned, pending funding.